Pros and cons of GLP-1 agonists and DPP-IV inhibitors

被引：0
|
作者：
Toft, Anders Dyhr [1 ]
机构：
[1] Novo Nordisk AS, Virum, Denmark
来源：
IDRUGS | 2007年 / 10卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：606 / 609
页数：4
相关论文
共 50 条
  • [41] From Theory to Clinical Practice in the Use of GLP-1 Receptor Agonists and DPP-4 Inhibitors Therapy
    Dicembrini, Ilaria
    Pala, Laura
    Rotella, Carlo Maria
    EXPERIMENTAL DIABETES RESEARCH, 2011,
  • [42] Preliminary results of patients receiving add-on treatment with an SGLT-2 inhibitor to DPP-IV or GLP-1 therapy
    Cordiner, R. L. M.
    Al-Hayali, M.
    Kernohan, A.
    DIABETIC MEDICINE, 2015, 32 : 204 - 204
  • [43] NVP-DPP728, a novel, orally active dipeptidyl peptidase IV (DPP-IV) inhibitor, prevents glucagon-like peptide-1 (GLP-1) inactivation in rats
    Hughes, TE
    Balkan, B
    Villhauer, EB
    DIABETES, 1999, 48 : A21 - A21
  • [44] Natural Products: Potential Source of DPP-IV Inhibitors
    Singla, Rajeev K.
    Kumar, Rishabh
    Khan, Sameer
    Mohit
    Kumari, Kajal
    Garg, Arun
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2019, 20 (12) : 1218 - 1225
  • [45] Predicting DPP-IV inhibitors with machine learning approaches
    Jie Cai
    Chanjuan Li
    Zhihong Liu
    Jiewen Du
    Jiming Ye
    Qiong Gu
    Jun Xu
    Journal of Computer-Aided Molecular Design, 2017, 31 : 393 - 402
  • [46] Predicting DPP-IV inhibitors with machine learning approaches
    Cai, Jie
    Li, Chanjuan
    Liu, Zhihong
    Du, Jiewen
    Ye, Jiming
    Gu, Qiong
    Xu, Jun
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2017, 31 (04) : 393 - 402
  • [47] Distinct front GLP-1 analogues, DPP-IV inhibitors do not appear weight neutral and to lack gastrointestinal side effects (vol 65, pg 157, 2007)
    Vervoort, G.
    Tack, C. J.
    NETHERLANDS JOURNAL OF MEDICINE, 2007, 65 (07): : 275 - 275
  • [48] The risk of acute pancreatitis with GLP-1 receptor agonists and DPP-4 inhibitors: a retrospective observational cohort study
    Koro, C. E.
    Sowell, M. O.
    Stender, M.
    Chhabra, P.
    Allen, J. K.
    Krzywy, H. J.
    DIABETOLOGIA, 2013, 56 : S183 - S184
  • [49] SGLT2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors and Risk of All-Cause Hospitalization
    Lyu, Beini
    Grams, Morgan
    Chang, Alex R.
    Inker, Lesley A.
    Coresh, Josef
    Shin, Jung-Im
    DIABETES, 2021, 70
  • [50] GLP-1 Agonists for Obesity
    Langland, James T.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (08):
12345